
- Mount Sinai Doctors
John Cijiang He, MD, PhD
Nephrology
About Me
Dr. John Cijiang He received his medical degree from Shanghai Second Medical University in China and his PhD in Physiology at University of Paris VII in France. He then received further research training as a visiting scientist at the Nationa Institutes of Health (NIH) in Maryland and the Picower Institute for Medical Research in New York. He completed his medical residency at SUNY Downstate and clinical nephrology fellowship at Mount Sinai Hospital in New York. Currently, Dr. He is Professor of Medicine and Pharmacological Sciences at the Icahn School of Medicine at Mount Sinai. He holds the title of Irene and Dr. Arthur Fishberg endowed chair of Nephrology. He is the chief of Nephrology at Mount Sinai Health System. He was the President of the New York Society of Nephrology and the President of Chinese American Society of Nephrology. He is member of the American Society of Clinical Investigation, and a visiting professor at both Nanjing University and Shanghai Jiaotong University. He has been funded by multiple NIH and VA grants and has published more than 180 papers in high-impact peer-reviewed scientific journals. His major research areas include glomerular cell biology, systems biology of kidney disease, and kidney fibrosis. Dr. He's clinical interest include diabetic kidney disease, viral-induced kidney disease, and primary glomerular disease.
Language
English
Position
PROFESSOR | Medicine, Nephrology, PROFESSOR | Pharmacological Sciences, PROFESSOR | Artificial Intelligence and Human Health
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Research Topics
Diabetes, HIV/AIDS, Kidney, Signal Transduction, Systems Biology
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT)
Clinical Focus
- Diabetic Kidney Disease
- Glomerulonephritis
- Kidney Failure
Education
MD, Shanghai 2nd Medical School
MD, St. George's School of Medicine
MS, University of Paris VII
, Rui-Jin Hospital, Shanghai 2nd Medical School
, Tenon Hospital
PhD, University of Paris VII
, Tenon Hospital
, SUNY Health Science Center
, SUNY Health Science Center
, The Mount Sinai Medical Center
Residency, Internal Medicine
State University of NY Health Science Center/Brooklyn
Fellowship, Nephrology
National Cancer Institute, NIH
Fellowship, Nephrology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Research
We have identified that HIPK2 plays a key role in kidney fibrosis. We are studying the mechanism of HIPK2 in mediating kidney fibrosis and try to identify potential anti-fibrosis therapy by targeting HIPK2. Please visit the He Laboratory.
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. He during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Boehringer Ingelheim International GmbH
- Renalytix AL
- Ono Pharmaceuticals
- Idorsia Pharmaceuticals Ltd
- Vera Therapeutics
- Yingli
Editorial Services
- Kidney International
Founder/Co-Founder/Partner
- Rila Therapeutics, Inc.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
